Consideration of sex/gender aspects in cardiovascular clinical trials
Our results suggest an ongoing imbalance for the participation of women/females and suboptimal SGR in cardiovascular clinical trials, especially for certain diseases, with a modest positive trend. More women/females in the authorship team correlate with an increased PPR and are associated with an increase in SGR.
Authors
- Maximilian Bley (ORCID: https://orcid.org/0000-0003-3019-8727)
- Marc Lerchenmueller (ORCID: https://orcid.org/0000-0001-8875-3602)
- I. Stephan
- Carolin Lerchenmüller (ORCID: https://orcid.org/0000-0002-5620-0285)
- Vera Regitz‐Zagrosek (ORCID: https://orcid.org/0000-0002-3566-3467)
- Susanne Menz
- Linda Mathez
Institutions
- Technische Hochschule Mannheim (DE)
- Centre for European Economic Research (DE)
- University of Mannheim (DE)
- University of Zurich (CH)
- Heidelberg University (DE)
- University Hospital Heidelberg (DE)
- Gender Studies (CZ)
- University Hospital of Zurich (CH)
- German Centre for Cardiovascular Research (DE)
- Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- Clinical Research in Cardiology
- Published
- 2025-11-26
- DOI
- https://doi.org/10.1007/s00392-025-02793-3
- Primary Topic
- Sex and Gender in Healthcare
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Universität Zürich